Priority Date: 10.08.12 (US 201261681918P)

PREDICTING BLADDER CANCER RESPONSIVENESS TO BCG

  • Application ID: EP13827381
  • Status: GRANT OF PATENT INTENDED

Applicant

Attorney

no operation time available
850.37
2 offices
active in Legal Services

Specialization

This EP application has the IPC combination A61, C12, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Avidity IP Ltd, Mewburn Ellis LLP and 76 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 10.08.2012 - Priority Date (US 201261681918P)
  • 13.02.2014 - Publication A1 (WO2014025892)
  • 17.06.2015 - Publication A1 (EP2882461)